UC Davis Medical Center is preparing to treat patients with some of the world’s most dangerous diseases. The Sacramento hospital will be Northern California’s first Special Pathogen Treatment Center, able to care for illnesses such as Ebola and Marburg virus, as reported by Davis Enterprise.
The medical center's new designation as a National Special Pathogens System Level 2 facility comes through $1.2 million in funding from the California Department of Public Health, marking a critical expansion of the state's outbreak response infrastructure. According to UC Davis Health, this investment will transform the facility into one of only two National Special Pathogens System hospitals providing specialized special pathogen assessment and treatment to California patients outside Los Angeles County, joining Cedars-Sinai Medical Center in this elite designation.
Filling a Critical Geographic Gap
The timing couldn't be more relevant, coming just months after Rwanda battled its largest-ever Marburg virus outbreak, which was declared over on December 20, 2024, after affecting healthcare workers in Kigali. The medical center, located at 2315 Stockton Boulevard in Sacramento, will serve a massive 65,000-square-mile region covering 33 counties and 6 million residents, positioning the facility as the primary response hub for emergencies spanning from California's Central Valley to the Oregon border.
Level 2 facilities are designed to deliver specialized care to clusters of patients and serve as primary centers for patient care throughout the duration of illness, as detailed by UC Davis Health. As a Level 2 center, UC Davis will be ready and able to safely receive, assess and provide care for people with risk for special pathogens infection, including Ebola and Marburg virus disease.
Building a Parallel System of Care
Dr. Christian Sandrock, director of critical care who will co-lead the new center alongside Dr. Angel Desai, associate professor of Infectious Diseases, emphasized the fundamental shift this represents. "Designing care for patients with highly contagious pathogens requires a fundamentally different approach," he explained to Mirage News. "We're building a parallel system — one that allows us to respond swiftly while keeping patients, health care workers and the broader community safe."
The transformation involves significant infrastructure upgrades funded by the state investment. The $1.2 million from CDPH includes maintenance of airborne infection isolation rooms, investment in specialized equipment, and enhanced training for medical staff to ensure safe and effective care for patients infected with special pathogens.
Strategic Partnership with Cedars-Sinai
The partnership between UC Davis and Cedars-Sinai creates a sophisticated two-tier system across California. As the regional Level 1 treatment facility, Cedars-Sinai will partner with UC Davis to help develop preparedness and response capabilities, enhancing the state's overall readiness. This collaboration ensures that Northern California residents won't need to travel to Los Angeles for specialized care during a pathogen emergency.
State Public Health Officer Dr. Erica Pan emphasized the strategic importance of this expansion in a statement. "CDPH will support UC Davis Medical Center in becoming a Special Pathogen Treatment Center, the second center that can serve statewide and the first in Northern California providing specialized assessment and treatment for California residents," she announced, as per Mirage News.
Built on Existing Excellence
The designation leverages UC Davis's existing strengths as an academic medical center. The facility already operates inland Northern California's only level I trauma center for both adult and pediatric emergencies and maintains access to nearly 1,000 research studies and help for complex conditions from experts in 150 areas of medicine. Recent recognition as the No. 1 hospital in the Sacramento region and No. 7 in California, according to U.S. News & World Report underscores the facility's clinical excellence.
Bruce Hall, interim vice chancellor of human health sciences and chief clinical officer, emphasized the multidisciplinary approach. "At UC Davis Health, our multidisciplinary team — including experts in infectious diseases, infection control, emergency medicine, security and preparedness — are ready to provide care for individuals with some of the most highly contagious infectious diseases."
Dr. Desai, who will co-lead the initiative, emphasized the center's regional role. "We are proud to be part of a robust network of hospitals dedicated to treating highly contagious infectious diseases," she shared. "Our exceptional team stands ready to serve as a vital resource for California and the broader region," as stated by Mirage News.
The center builds on UC Davis's established infectious disease expertise, including leadership in HIV and AIDS treatment over the past three decades and being at the forefront of COVID-19 treatment, vaccine development and clinical trials since the pandemic began. The Division of Infectious Diseases operates from the Lawrence J. Ellison Ambulatory Care Center at 4860 Y Street, Suite 0101, and maintains a major Northern California referral center for infectious diseases treatment.
